Blevins T, Mitchell M, Korom M, Wang H, Yu Y, Morrison L
PLoS One. 2015; 10(12):e0144738.
PMID: 26658766
PMC: 4682838.
DOI: 10.1371/journal.pone.0144738.
Kaul T, Welliver R, Ogra P
J Clin Microbiol. 1981; 13(5):957-62.
PMID: 7016915
PMC: 273923.
DOI: 10.1128/jcm.13.5.957-962.1981.
Ohashi M, Ozaki Y
Arch Virol. 1981; 67(1):57-69.
PMID: 6263224
DOI: 10.1007/BF01314602.
Baughman R, Fenters J, MARQUIS Jr G, Holper J
Appl Microbiol. 1968; 16(7):1076-80.
PMID: 5664124
PMC: 547591.
DOI: 10.1128/am.16.7.1076-1080.1968.
Rossi C, KIESEL G
Arch Gesamte Virusforsch. 1974; 45(4):328-34.
PMID: 4374159
DOI: 10.1007/BF01242876.
Antibody to viruses affecting cattle in commercial tissue culture grade fetal calf serum.
Rossi C, KIESEL G
Appl Microbiol. 1974; 27(1):114-7.
PMID: 4358857
PMC: 379977.
DOI: 10.1128/am.27.1.114-117.1974.
Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody.
Kim K, Carp R
J Virol. 1973; 12(6):1620-1.
PMID: 4357520
PMC: 356807.
DOI: 10.1128/JVI.12.6.1620-1621.1973.
Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders.
Aston D, Cohen A, Spindler M
Br Med J. 1972; 4(5838):462-5.
PMID: 4347337
PMC: 1786731.
DOI: 10.1136/bmj.4.5838.462.
The influence of complement on cytomegalovirus neutralization by antibodies.
Andersen H
Arch Gesamte Virusforsch. 1972; 36(1):133-40.
PMID: 4335019
DOI: 10.1007/BF01250303.
Serologic differentiation of human cytomegalovirus strains using rabbit hyperimmune sera. Brief report.
Andersen H
Arch Gesamte Virusforsch. 1971; 33(1):187-91.
PMID: 4325973
DOI: 10.1007/BF01254177.
Effect of heat-labile factors on the neutralization of vaccinia virus by human.
Takabayashi K, McIntosh K
Infect Immun. 1973; 8(4):582-9.
PMID: 4200542
PMC: 422895.
DOI: 10.1128/iai.8.4.582-589.1973.
Monoclonal antibodies: implications for virology. Brief review.
Mccullough K
Arch Virol. 1986; 87(1-2):1-36.
PMID: 3510607
DOI: 10.1007/BF01310540.
Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.
SCHMIDT N, Forghani B, LENNETTE E
Infect Immun. 1975; 12(4):728-32.
PMID: 1193713
PMC: 415348.
DOI: 10.1128/iai.12.4.728-732.1975.
Antibody class and complement requirement of neutralizing antibodies in the primary and secondary antibody response of cattle to infectious bovine rhinotracheitis virus vaccine.
Rossi C, KIESEL G
Arch Virol. 1976; 51(3):191-8.
PMID: 184759
DOI: 10.1007/BF01318023.
Induction of herpes simplex virus immunity in newborn mice.
Koyama H, Kasahara S
Infect Immun. 1975; 12(6):1472-4.
PMID: 173657
PMC: 415458.
DOI: 10.1128/iai.12.6.1472-1474.1975.
Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells.
Austin R, Daniels C
Infect Immun. 1975; 12(4):821-7.
PMID: 172447
PMC: 415362.
DOI: 10.1128/iai.12.4.821-827.1975.
Neutralizing antibody responses to varicella-zoster virus.
SCHMIDT N, LENNETTE E
Infect Immun. 1975; 12(3):606-13.
PMID: 170206
PMC: 415330.
DOI: 10.1128/iai.12.3.606-613.1975.
Neutralization of animal viruses.
Mandel B
Adv Virus Res. 1978; 23:205-68.
PMID: 107731
PMC: 7131355.
DOI: 10.1016/s0065-3527(08)60101-3.
